Trial Profile
Planned dose-escalating study to investigate the tolerability of a wide range of doses of BLX 155 in patients with haemodialysis graft thrombosis.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 02 Aug 2007
Price :
$35
*
At a glance
- Drugs BLX 155 (Primary)
- Indications Thrombosis
- Focus Adverse reactions
- 02 Aug 2007 New trial record.